Schedule 13G ownership disclosure

ADAPTIMMUNE THERAPEUTICS PLC

Ordinary Shares, par value GBP 0.001 per share · CUSIP: 00653A107

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Two Seas Capital LP

    Shares: 89,010,876 · Class: 5.8%

  • Two Seas Capital GP LLC

    Shares: 89,010,876 · Class: 5.8%

  • Sina Toussi

    Shares: 89,010,876 · Class: 5.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001011438-25-000145
Form type
SCHEDULE 13G
Filer
Adaptimmune Therapeutics PLC
CIK
CIK 1621227
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub